HOME › DRUGS › FINERENONE
ACTIVE SUBSTANCE / INN

FINERENONE

Brand name(s): KERENDIA, Kerendia
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Renal Insufficiency, Chronic;Diabetes Mellitus, Type 2
NDA215341
ACTIVE SUBSTANCE
Finerenone
REGULATORS
FDA · EMA
SPONSORS / MAH
Bayer AG, BAYER HLTHCARE
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KERENDIANDA215341BAYER HLTHCAREPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KerendiaBayer AGAuthorised16/02/2022Renal Insufficiency, Chronic;Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON FINERENONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →